Ende Eric J is a director of Matinas BioPharma Holdings, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
AVADEL PHARMACEUTICALS PLC
1 Aug 24
4
Matinas BioPharma Holdings, Inc.
3 Nov 23
4
AVADEL PHARMACEUTICALS PLC
3 Aug 23
4
AVADEL PHARMACEUTICALS PLC
19 May 23
4
AVADEL PHARMACEUTICALS PLC
23 Nov 22
4
Matinas BioPharma Holdings, Inc.
16 Nov 22
4
NeuBase Therapeutics, Inc.
12 Sep 22
4
AVADEL PHARMACEUTICALS PLC
5 Aug 22
4
AVADEL PHARMACEUTICALS PLC
1 Jun 22
4
AVADEL PHARMACEUTICALS PLC
31 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Jul 24 | AVDL Avadel Pharmaceuticals | Ordinary Shares | Grant | Acquire A | No | No | 0 | 11,000 | 0.00 | 178,900 |
30 Jul 24 | AVDL Avadel Pharmaceuticals | Stock Option Ordinary Shares | Grant | Acquire A | No | No | 16.32 | 11,000 | 179.52 k | 11,000 |
1 Nov 23 | MTNB Matinas BioPharma | Stock option Common Stock | Grant | Acquire A | No | No | 0.2088 | 437,244 | 91.30 k | 437,244 |
1 Aug 23 | AVDL Avadel Pharmaceuticals | Stock Option ADSs | Grant | Acquire A | No | No | 14.1 | 33,000 | 465.30 k | 33,000 |
18 May 23 | AVDL Avadel Pharmaceuticals | ADSs | Buy | Acquire P | No | No | 13.9308 | 13,000 | 181.10 k | 167,900 |